ALKSMID

Alkermes plc

HealthcareBiotechnology
$46.02
$0.00(+1.08%)
52W$25.17
$46.63
Updated Jun 22, 02:00 AM
RSI71
RS Rating88/99
Beta0.88
Volatility41%
F-Score7/9
Mkt Cap$7.7B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Alkermes plc is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings contraction of 408% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
88
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.88
vs S&P 500
DEFENSIVE
52W Position
97%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$38.07
50 SMA > 100 SMA$34.77
100 SMA > 150 SMA$33.01
150 SMA > 200 SMA$32.26

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$42.53+8.20%ABOVE
50 SMA$38.07+20.90%ABOVE
100 SMA$34.77+32.37%ABOVE
150 SMA$33.01+39.40%ABOVE
200 SMA$32.26+42.67%ABOVE

Price Performance

1D+1.1%
1W+0.2%
1M+21.0%
3M+65.4%
6M+61.8%
YTD+59.2%
1Y+53.4%
3Y+11.5%
52-Week Trading Range97% from low
$46.02
52W Low$25.17
52W High$46.63

Technical Indicators

RSI (14)OVERBOUGHT
71.0
305070
Setup ScoreCOOL
3/10
Base depth: 38.0%

Risk Profile

Beta
0.88
52W Vol
41%
ATR
$1.62
Max DD (1Y)
-22%

Volume Analysis

Today
3.09M
50D Avg
1.89M
Vol Ratio
1.63x
Liquidity
LIQUID

Earnings Momentum

Q2'25-2%
$0.52
Q3'25-11%
$0.49
Q4'25-67%
$0.29
Q1'26-408%
$-0.40
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+8.91%
5 Years:+7.28%
3 Years:+9.90%
TTM:+3.21%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-56.94%

Stock Price CAGR

10 Years:+0.72%
5 Years:+13.00%
3 Years:+11.53%
1 Year:+53.39%

Return on Equity

10Y Avg:-1.4%
5Y Avg:11.0%
3Y Avg:24.6%
Last Year:8.8%

Key Metrics

Market Cap$7.7B
Gross Margin86.7%
Net Margin16.4%
Piotroski F-Score7/9

Frequently Asked Questions

Is ALKS in an uptrend right now?

ALKS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ALKS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is ALKS overbought or oversold?

ALKS's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is ALKS outperforming the market?

ALKS has a Relative Strength (RS) Rating of 88 out of 99. Yes, ALKS is a market leader, outperforming 88% of all stocks over the past 12 months.

Where is ALKS in its 52-week range?

ALKS is trading at $46.02, which is 99% of its 52-week high ($46.63) and 97% above its 52-week low ($25.17).

How volatile is ALKS?

ALKS has a Beta of 0.88 and 52-week volatility of 41%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.